Cardiff Oncology, Inc. (CRDF) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cardiff Oncology, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -4.10x | -4.55x | -1.60x | -1.58x | -8.29x | -19.45x |
| P/B Ratio | 4.14x | 2.49x | 0.95x | 0.57x | 1.67x | 2.93x |
| P/S Ratio | 316.73x | 302.78x | 135.50x | 158.13x | 653.40x | 1026.07x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -8256.3% | -7123.1% | -9305.7% | -10337.3% | -8037.6% | -5214.8% |
| Net Margin | -7732.0% | -6651.7% | -8492.0% | -10026.9% | -7880.5% | -5275.1% |
| EBITDA Margin | -8103.9% | -7064.0% | -9224.2% | -10276.2% | -7912.0% | -5147.3% |
| Liquidity | ||||||
| Current Ratio | 3.67x | 7.08x | 7.41x | 14.25x | 22.28x | 21.79x |
| Quick Ratio | 3.67x | 7.08x | 7.41x | 14.25x | 22.28x | 21.79x |
| Leverage | ||||||
| Debt/Equity | 0.02x | 0.02x | 0.03x | 0.03x | 0.02x | 0.01x |
YoY = year-over-year change. Source: FMP..